Table 5.
GERD therapy regimens documented in PCP and GE medical charts
| PCP N = 100 charts | GE N = 99 chartsa | |
|---|---|---|
| N (%) | N (%) | |
| Documentation of antacid use | 17 (17.0%) | 7 (7.1%) |
| Documentation of PPI use | 88 (88.0%) | 84 (84.8%) |
| Documentation of H2RA use | 26 (26.0%) | 14 (14.1%) |
| Reasons for change in GERD therapy regimen over time | ||
| Any change in GERD therapy regimen over time | 60 (60.0%) | 42 (42.4%) |
| Symptoms did not change or worsened | 31 (51.7%)b | 4 (9.5%)c |
| Patient did not respond to therapy | 31 (51.7%)b | 11 (26.2%)c |
| Change in insurance coverage | 4 (6.7%)b | 1 (2.4%)c |
| Patient request | 2 (3.3%)b | 0 |
| Symptoms improved | 0 | 3 (7.1%)c |
| EGD results | 0 | 8 (19.0%)c |
| Other reason | 6 (10.0%)b | 6 (14.3%)c |
| No information in chart | 9 (15.0%)b | 13 (31.0%)c |
PCP primary care physician, GE gastroenterologist, PPI proton pump inhibitor, H2RA H2-receptor antagonist, EGD esophagogastroduodenoscopy
aOne GE chart had no information about the subject during the designated time period, thus data from 99 GE charts were analyzed
bPercentages are proportions of 60 PCP charts with documentation of change in GERD therapy regimen over time
cPercentages are proportions of 42 GE charts with documentation of change in GERD therapy regimen over time; multiple responses could be selected